Intercalated Cells are specialized epithelial cells primarily found in the renal collecting ducts of the kidneys, contributing to the regulation of acid-base balance and maintaining overall homeostasis. These cells are essential components of the nephron, the functional unit of the kidney. Intercalated cells exist in two forms: type A and type B. Type A intercalated cells are primarily responsible for secreting hydrogen ions and reabsorbing bicarbonate ions, playing a pivotal role in maintaining the pH balance of the blood. On the other hand, type B intercalated cells are involved in the secretion of bicarbonate ions and the reabsorption of hydrogen ions. The intricate activities of these cells are crucial for preventing acidosis or alkalosis, ensuring the body's internal environment remains within a narrow pH range. Intercalated cells achieve these functions through the expression of various transport proteins, ion channels, and enzymes. Dysfunction of intercalated cells can lead to electrolyte imbalances and acid-base disorders, impacting overall kidney function. Understanding the physiology of intercalated cells is crucial for unraveling the complexities of renal physiology and has implications for the diagnosis and treatment of conditions related to acid-base balance and kidney function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy